Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 42: 1765-1769, 1996;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mularoni, A.
Right arrow Articles by Nicollier, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mularoni, A.
Right arrow Articles by Nicollier, M.

Clinical Chemistry, Vol 42, 1765-1769, Copyright © 1996 by American Association for Clinical Chemistry

Competitive RT-PCR to quantify CFTR mRNA in human endometrium

A Mularoni, GL Adessi, F Arbez-Gindre, G Agnani and M Nicollier
Service de Biochimie, Centre Hospitalier Universitaire, Besancon, France.

Because the down-regulation by progesterone of cystic fibrosis transmembrane conductance regulator (CFTR) expression could be a useful specific marker to define the state of implant receptivity in endometrium, a competitive reverse transcription-polymerase chain reaction (RT-PCR) was developed for quantifying the CFTR mRNA concentration in human endometrial samples. A competitor RNA was constructed with the same sequence as the CFTR sequence except for a 20- nucleotide insertion in the middle. The amplified products were separated by polyacrylamide gel electrophoresis. The ratio of CFTR band areas to competitor band areas provided the basis of quantification. Using this competitive RT-PCR, we measured CFTR mRNA in human endometrial samples taken at different periods of the menstrual cycle, in endometriosis, and in hyperplasia. Results show that the method is suitable for measuring the concentration of CFTR mRNA.


The following articles in journals at HighWire Press have cited this article:


Home page
 Hum ReprodHome page
X.-Y. Zheng, G.-A. Chen, and H.-Y. Wang
Expression of cystic fibrosis transmembrane conductance regulator in human endometrium
Hum. Reprod., December 1, 2004; 19(12): 2933 - 2941.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. M. Loitsch, S. Kippenberger, N. Dauletbaev, T. O.F. Wagner, and J. Bargon
Reverse Transcription-Competitive Multiplex PCR Improves Quantification of mRNA in Clinical Samples—Application to the Low Abundance CFTR mRNA
Clin. Chem., May 1, 1999; 45(5): 619 - 624.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
L.N. Chan, Y.W. Chung, P.S. Leung, C.Q. Liu, and H.C. Chan
Activation of an Adenosine 3',5'-Cyclic Monophosphate-Dependent Cl- Conductance in Response to Neurohormonal Stimuli in Mouse Endometrial Epithelial Cells: The Role of Cystic Fibrosis Transmembrane Conductance Regulator
Biol Reprod, February 1, 1999; 60(2): 374 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. Revillion, L. Hornez, and J.-P. Peyrat
Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCR
Clin. Chem., November 1, 1997; 43(11): 2114 - 2120.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Association for Clinical Chemistry.